Researcher.Life Logo

–°–∏—Å—Ç–µ–º–Ω—ã–µ –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏ : Impact Factor & More

eISSN: 2542-2189pISSN: 2075-082X
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

–°–∏—Å—Ç–µ–º–Ω—ã–µ –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏ Journal Specifications

Overview
Publisher IP Morozov P.V.
Language Russian
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageRussian
Society/Institute/Sponsorthe Russian society of hypertension
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in –°–∏—Å—Ç–µ–º–Ω—ã–µ –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏ ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in –°–∏—Å—Ç–µ–º–Ω—ã–µ –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏

Physicians and medical students’ knowledge assessment in matters of classification and definition of arterial hypertension based on the multicenter PHYSTARH-II study results
  • 29 Oct 2025
  • Systemic Hypertension
Obstructive sleep apnea and early kidney damage in young and middle-aged men with arterial hypertension
  • 29 Oct 2025
  • Systemic Hypertension
Medical Society of Hypertension. Use of beta-blockers in patients with hypertension
  • 29 Oct 2025
  • Systemic Hypertension
Features of diagnostic search and choice of treatment strategy in patients with chronic thromboembolic pulmonary hypertension associated with systemic lupus erythematosus and antiphospholipid syndrome: case report
  • 29 Oct 2025
  • Systemic Hypertension
The place of a new fixed combination Valsacor® INDA (valsartan and indapamide) in the treatment of patients with various phenotypes of arterial hypertension (resolution of the Council of Experts)
  • 29 Oct 2025
  • Systemic Hypertension
Validation of noninvasive screening methods for pulmonary arterial hypertension in patients with systemic sclerosis
  • 27 Jun 2025
  • Systemic Hypertension
Physicians and medical students’ knowledge assessment in matters of classification and definition of arterial hypertension based on the multicenter PHYSTARH-II study results
  • 29 Oct 2025
  • Systemic Hypertension
Obstructive sleep apnea and early kidney damage in young and middle-aged men with arterial hypertension
  • 29 Oct 2025
  • Systemic Hypertension
Medical Society of Hypertension. Use of beta-blockers in patients with hypertension
  • 29 Oct 2025
  • Systemic Hypertension
Features of diagnostic search and choice of treatment strategy in patients with chronic thromboembolic pulmonary hypertension associated with systemic lupus erythematosus and antiphospholipid syndrome: case report
  • 29 Oct 2025
  • Systemic Hypertension
The place of a new fixed combination Valsacor® INDA (valsartan and indapamide) in the treatment of patients with various phenotypes of arterial hypertension (resolution of the Council of Experts)
  • 29 Oct 2025
  • Systemic Hypertension
Validation of noninvasive screening methods for pulmonary arterial hypertension in patients with systemic sclerosis
  • 27 Jun 2025
  • Systemic Hypertension

FAQs on –°–∏—Å—Ç–µ–º–Ω—ã–µ –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏